Category: CLSI

Newborn Screening for Cystic Fibrosis; Approved Guideline (Formerly I/LA35-A), NBS05AE
standard by Clinical and Laboratory Standards Institute,

Establishing Molecular Testing in Clinical Laboratory Environments; Proposed Guideline, MM19AE
standard by Clinical and Laboratory Standards Institute, 11/01/2011

Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Eleventh Edition / Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Eighth Informational Supplement, M07Ed11E, M100Ed28E
standard by Clinical and Laboratory Standards Institute, 01/01/2018

Assessment of Equivalence or Suitability of Specimen Types for Medical Laboratory Measurement Procedures, 1st Edition, EP35Ed1E
standard by Clinical and Laboratory Standards Institute, 12/01/2019

Quality Management System: Development and Management of Laboratory Documents; Approved Guideline-Sixth Edition, QMS02A6E
standard by Clinical and Laboratory Standards Institute, 02/28/2013

Performance Standards for Antimicrobial Disk Susceptibility Tests, Thirteenth Edition, M02Ed13E; Performance Standards for Antimicrobial Susceptibility Testing, Twenty-Ninth Edition, M100Ed29E
standard by Clinical and Laboratory Standards Institute, 12/27/2018

Development of In Vitro Susceptibility Testing Criteria and Quality Control Parameters; 4th Edition M23Ed4E
standard by Clinical and Laboratory Standards Institute, 01/01/2016

Supplemental Tables for Interference Testing in Clinical Chemistry, 1st Edition, EP37Ed1E
standard by Clinical and Laboratory Standards Institute, 04/01/2018

Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacterial Isolated from Animals; Approved Standard-Fourth Edition and Supplement, VET01A4E and VET01S3E
standard by Clinical and Laboratory Standards Institute, 06/01/2015

Newborn Screening by Tandem Mass Spectrometry, NBS04Ed2E
standard by Clinical and Laboratory Standards Institute, 05/01/2017